Regeneron receives FDA approval for EYLEA HD
diabetic macular edema

Regeneron receives FDA approval for EYLEA HD

The Food and Drug Administraton (FDA) gave approval after two active-controlled, double-masked pivotal trials, which compared EYLEA HD to EYLEA over a 48 week period.
FDA approves Izervay for treatment of geographic atrophy
AMD

FDA approves Izervay for treatment of geographic atrophy

The Food and Drug Administration (FDA) recently announced their approval of Izervay for treatment of geographic atrophy (GA) secondary to age-related macular degeneration.
New anti-VEGF therapy shows promise in Phase 1 Clinical trial
anti-VEGF

New anti-VEGF therapy shows promise in Phase 1 Clinical trial

The new drug is manufactured by 4D Molecular Therapeutics and is a dual-transgene intravitreal gene therapy.
AI algorithm may be a helpful tool for determining progression of AMD
AMD

AI algorithm may be a helpful tool for determining progression of AMD

Artificial intelligence may be the key in helping doctors determine which patients with intermediate AMD are at a high risk of the disease progressing to geographic atrophy.
Anti-VEGF treatment for wet AMD may hasten progression of glaucoma
age-related macular degeneration

Anti-VEGF treatment for wet AMD may hasten progression of glaucoma

Researchers concluded that anti-VEGF treatments do raise the risk of glaucoma progression.
One neovascular AMD treatment more effective than the other
AMD

One neovascular AMD treatment more effective than the other

A recent study reveals that one anti-VEGF treatment is more effective than another commonly used treatment.
Eye implant to treat wet macular degeneration approved by FDA
AMD

Eye implant to treat wet macular degeneration approved by FDA

The device is the size of a grain of rice and is refilled every six months.
Study indicates some patients may be "weaned" off injections for wet macular degeneration
age-related macular degeneration

Study indicates some patients may be "weaned" off injections for wet macular degeneration

Study results offer hope to patients with wet macular degeneration who are receiving anti-VEGF injections.
Gene Therapy for Macular Degeneration positive results
age-related macular degeneration

Gene Therapy for Macular Degeneration positive results

For patients suffering from age-related macular degeneration, gene therapy has the potential to transfigure the treatment options that are available.

Order 3 bottles & get Free Shipping

Or subscribe and get free shipping every month!